Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1991 | 09-1991 | 06-1991 | 03-1991 | 12-1990 | |
| Sales | 756 | 1,557 | 1,113 | 1,284 | 4,497 |
| Cost of Goods | 3,649 | 3,764 | 3,815 | 3,890 | 10,810 |
| Gross Profit | -2,893 | -2,207 | -2,701 | -2,606 | 4,497 |
| Operating Expenses | 1,966 | 1,529 | 1,747 | 1,779 | 4,998 |
| Operating Income | -4,211 | -2,972 | -3,634 | -3,495 | -10,501 |
| Interest Expense | 15 | 19 | 20 | 18 | 20 |
| Other Income | 219 | 81 | 124 | 167 | 7,238 |
| Pre-tax Income | -4,007 | -2,910 | -3,530 | -3,346 | -3,283 |
| Net Income Continuous | -4,007 | -2,910 | -3,530 | -3,346 | -3,283 |
| Net Income | $-4,007 | $-2,910 | $-3,530 | $-3,346 | $-3,283 |
| EPS Basic Total Ops | -40,073.00 | -29,104.00 | -35,296.00 | -33,455.00 | -32,832.00 |
| EPS Basic Continuous Ops | -40,073.00 | -29,104.00 | -35,296.00 | -33,455.00 | -32,832.00 |
| EPS Diluted Total Ops | -40,073.00 | -29,104.00 | -35,296.00 | -33,455.00 | -32,832.00 |
| EPS Diluted Continuous Ops | -40,073.00 | -29,104.00 | -35,296.00 | -33,455.00 | -32,832.00 |
| EBITDA(a) | $-4,211 | $-2,972 | $-3,634 | $-3,495 | $-10,501 |